CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | January/February 2020

Making Sense of ORBITA and ISCHEMIA

Discussing the contributions of the ORBITA and ISCHEMIA trials to the ongoing debate surrounding revascularization in stable coronary artery disease.

By Michael Foley, MBBS, MRCP, and Rasha Al-Lamee, MRCP, PhD

cit | Article | January/February 2020

PCI in Practice and Update on Mechanical Circulatory Support

By Christopher Cook, BSc, MBBS, MRCP, PhD, and M. Chadi Alraies, MD

cit | News | September 28, 2021

Neovasc’s Reducer Device for Refractory Angina Evaluated in Interim Data From REDUCER-I Study

September 28, 2021—Neovasc Inc. announced the publication of interim results from the multicenter, prospective, open-label REDUCER-I clinical study investigating patients with refractory angina treated with the Neovasc Reducer system.

cit | News | April 8, 2024

ORBITA-COSMIC Evaluates Coronary Sinus Reducer to Treat Refractory Angina

April 8, 2024—The placebo-controlled ORBITA-COSMIC study met one of its primary endpoints by showing symptom improvement with a coronary sinus reducer (CSR) at 6 months; however, it did not meet the main primary endpoint, which was designed to determine the mechanism by which the CSR might work.

Advertisement

Advertisement

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

TAVR Optimization Using Best Practices

By Mathew Williams, MD; Michael Querijero, MSPA; and Tara Collins, MSPA; on behalf of New York University Langone Medical Center, New York, NY

Sponsored by Edwards Lifesciences

cit | Article | September/October 2025 Supplement

TAVR Economics

How partnerships, a lean program, and a holistic view can grow structural heart programs.

By Andrei Pop, MD, and Michael Busky

cit | Article | March/April 2021

An Interview With Rasha Al-Lamee, MA, MBBS, FRCP, PhD

Dr. Al-Lamee discusses the importance of research in cardiology care, thoughts on the ORBITA and EXCEL trials, and the effect of COVID-19 on the clinical trial landscape.

cit | Article | January/February 2024

Mechanical Circulatory Support Use in Cardiogenic Shock and Complex PCI

An overview of mechanical circulatory support devices and simplified algorithms for their optimal use in cardiogenic shock and complex, high-risk interventions.

By Mahmoud Khalil, MD; Hossam Albeyoumi Mohammed, MD; Lindsey Cilia, MD; Khaldoon Alaswad, MD; and Michael Megaly, MD


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button